Sign In
18 Mar 2010 07:00

The following release replaces RNS 7580I announced on 17 March 2010 at 17.21.
This release contains an amendment to the dates set out under column title 'Exercise Period'
Â
Â
For immediate release 18 March 2010
Â
Â
Â
Directors' Dealings
Â
Brady plc ("the Company") announces that on 16 March 2010 the Company granted to Brian Collins, Product Management Director, options at nil-cost over 75,000 Ordinary Shares of 1p each in the Company. The exercise price of 66.5 pence per share is the closing middle market price on 16 March 2010. The vesting of individual share option tranches is subject to the individual remaining employed with the Company at the relevant vesting dates.
Â
Further details of the share option grants are set out below:
Â
|
Director |
Options granted |
Exercise price per Share  |
Exercise Period  |
|
Brian Collins |
18,750 |
66.5 pence |
17 March 2011 to 16 March 2017 |
|
|
18,750 |
66.5 pence |
17 March 2012 to 16 March 2017 |
|
|
18,750 |
66.5 pence |
17 March 2013 to 16 March 2017 |
|
|
18,750 |
66.5 pence |
17 March 2014 to 16 March 2017 |
The total number of shares under option for Brian Collins following this grant is 225,000.
Â
Â
For further information please contact:
Â
|
Brady plc Gavin Lavelle, Chief Executive Officer Tony Ratcliffe, Finance Director |
Telephone: +44(0)1223 479479 |
|
 Cenkos Securities Limited Ivonne Cantu / Alex Aylen  |
 Telephone: +44 (0)20 7397 8900 |
Â
Follow the stocks
